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Campylobacter jejuni is the most common cause of bacterium-mediated diarrheal disease in humans worldwide.
Poultry products are considered the most important source of C. jejuni infections in humans but to date no effective
strategy exists to eradicate this zoonotic pathogen from poultry production. Here, the potential use of passive
immunization to reduce Campylobacter colonization in broiler chicks was examined. For this purpose, laying hens
were immunized with either a whole-cell lysate or the hydrophobic protein fraction of C. jejuni and their eggs were
collected. In vitro tests validated the induction of specific ImmunoglobulinY (IgY) against C. jejuni in the immunized
hens’ egg yolks, in particular. In seeder experiments, preventive administration of hyperimmune egg yolk significantly
(P < 0.01) reduced bacterial counts of seeder animals three days after oral inoculation with approximately 104 cfu C.
jejuni, compared with control birds. Moreover, transmission to non-seeder birds was dramatically reduced (hydrophobic
protein fraction) or even completely prevented (whole-cell lysate). Purified IgY promoted bacterial binding to chicken
intestinal mucus, suggesting enhanced mucosal clearance in vivo. Western blot analysis in combination with mass
spectrometry after two-dimensional gel-electrophoresis revealed immunodominant antigens of C. jejuni that are
involved in a variety of cell functions, including chemotaxis and adhesion. Some of these (AtpA, EF-Tu, GroEL and CtpA)
are highly conserved proteins and could be promising targets for the development of subunit vaccines.Introduction
Today, campylobacteriosis is the most frequently re-
ported zoonotic diarrheal disease worldwide, with
Campylobacter jejuni as the major causative agent [1].
Despite many efforts aimed at minimizing Campylobacter
contamination of poultry, no effective, reliable interven-
tion measures exist to reduce bacterial numbers in the
broiler gut [2]. In general, broiler chickens become colo-
nized from the age of two weeks onward [3]. Transporta-
tion of immunoglobulin (Ig) Y, the major Ig class in
chickens, from hen to embryo via egg yolk is believed to
play a key role in the protection of young chicks with
an immature immune system against Campylobacter
colonization during two to three weeks post-hatch
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reproduction in any medium, provided the ormaternally derived anti-Campylobacter IgY drops signifi-
cantly, which coincides with an increased colonization
susceptibility of the broiler chicks. Passive immunization
of chicks may be prolonged by feeding broilers with high
levels of anti-Campylobacter antibodies recovered from
immunized hens [4]. Following immunization, specific IgY
is induced and transferred from the serum to the egg yolk
[4], where it is accumulated at high levels [6]. Indeed, pre-
incubating C. jejuni with IgY from immunized hens has
previously been shown to reduce fecal C. jejuni counts in
broilers experimentally inoculated with this mixture [7].
In this study, also the effect of IgY on colonization in
already-colonized animals was assessed. Results indicated
that IgY induced only a limited therapeutic efficacy. After
an initial drop, fecal C. jejuni numbers regained their ori-
ginal counts when treatment was stopped. Nevertheless,
these observations indicate that IgY preparations from egg
yolks could be a promising candidate to reduce C. jejuni
colonization in broilers, but need to be optimized becauseal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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over, in the study by Tsubokura et al. [7] fecal bacterial
counts were determined, which may not perfectly correl-
ate to determining cecal counts, which is more sensitive
[8]. In the past two decades, some promising observations
have been reported concerning the use of chicken egg yolk
Igs in animal models and humans for the prevention and
treatment of other bacterial and viral diseases, including
streptococci [9], Helicobacter pylori [10], human rotavirus,
enterotoxigenic Escherichia coli, Yersinia ruckeri and
Salmonella species [4,11]. In these studies, protection
was primarily observed after infection with the homolo-
gous strain.
Passive immunization using yolk IgY thus seems a
promising strategy to control C. jejuni colonization in
broiler flocks. For this purpose, the first aim of this study
was to examine whether hyperimmune egg yolk could
reduce or prevent cecal C. jejuni colonization in broiler
chicks. The second objective was to identify the C. jejuni
antigens reacting with C. jejuni-specific IgY raised in
chicken eggs.Materials and methods
Experimental animals
Commercial brown Leghorn laying hens and day-of-
hatch Ross broiler chickens of both sexes from a local
farm were raised in group until treatment. Birds were
provided with a commercial feed and water ad libitum.
Husbandry, euthanasia methods, experimental proce-
dures and bio-safety precautions were approved by the
Ethical Committee (EC) of the Faculty of Veterinary
Medicine, Ghent University, Ghent, Belgium (EC num-
bers: 2010/174 and 2011/029). Chicks were examined
for the presence of Campylobacter in mixed fecal sam-
ples using standard methods as described in [12] and
proved to be free of Campylobacter.Bacterial strains and culture conditions
C. jejuni strain KC40 from poultry origin was used for
all experiments. This strain colonizes chickens to a
high level [12,13]. Bacteria were routinely cultured in
Nutrient Broth No.2 (NB2, CM0067; Oxoid Ltd.,
Basingstoke, Hampshire, UK) supplemented with Modified
Preston Campylobacter-selective supplement (SR0204E;
Oxoid) and Campylobacter-specific growth supplement
(SR0232E; Oxoid), at 42 °C under microaerobic conditions
(5% O2, 5% CO2, 5% H2, 85% N2). C. jejuni bacteria were
enumerated by preparing 10-fold dilutions in Hank’s
Balanced Salt Solution (HBSS; GIBCO-BRL, Invitrogen,
Carlsbad, CA, USA) and plating on modified charcoal
cefoperazone deoxycholate agar (mCCDA, CM0739;
Oxoid) supplemented with CCDA selective supple-
ment (SR0155E; Oxoid) and Campylobacter-specificgrowth supplement, followed by microaerobic incuba-
tion at 42 °C for 22 h.
Extraction of C. jejuni hydrophilic and hydrophobic
proteins
To prepare the immunizing agent, cells from a C. jejuni
culture were collected by centrifugation (5000 × g for
30 min at 4 °C), washed in HBSS and sonicated on ice
for 30 s in extraction buffer 1 (EB1; 40 mM Tris, supple-
mented with tributylphosphine solution, protease inhibi-
tor cocktail, phosphatase inhibitors PP2 and PP3, DNase
and RNase (Sigma-Aldrich, Steinheim, Germany) using a
tip sonicator (Qsonica, Newtown, VS). After each sonic-
ation step, 12 in total, the sample was left on ice for 30 s.
After centrifugation at 16 000 × g for 10 min at 4 °C the
supernatant (containing the hydrophilic proteins) was col-
lected and the pellet resuspended in extraction buffer 2
(EB2; 40 mM Tris, supplemented with 5M urea, 2M
thiourea, 2% 3-[(3-cholamidopropyl)dimethylammonio]-
1-propanesulfonate (CHAPS), 0.2% carrier ampholytes,
100 mM dithiothreitol (DTT) and the respective inhibitors
as mentioned above). After sonication and centrifugation
of the latter suspension at 5000 × g for 3 min to remove
cell debris and non-lysed cells, the supernatant (contain-
ing the hydrophobic proteins) was either pooled with the
first supernatant (to obtain the whole-cell protein lysate)
or stored (−20 °C) separately.
Immunization of laying hens
Campylobacter-free commercial Brown Leghorn chick-
ens were randomly assigned to vaccination groups at the
age of 19 weeks. Chickens were immunized with either
50 μg of the C. jejuni KC40 whole-cell lysate (EB1 + EB2)
or 25 μg protein of the hydrophobic protein fraction only
(EB2), by intramuscular injection of 250 μL of a 1:1 mix-
ture with Freunds’ Complete Adjuvant (FCA) at four dif-
ferent sites of the pectoral muscle. Chicks of the control
group were immunized with a mixture of HBSS and FCA.
Starting from the age of 21 weeks, three booster immuni-
zations using Freunds’ Incomplete Adjuvant (FIA) were
given in a two-weekly time interval. Starting from one
week after the second boost, eggs of the animals were
collected and stored at 4 °C.
Determination of egg yolk and white IgY, IgA and IgM titers
At weekly time intervals, starting from the day of the
first immunization, eggs were collected from both
groups. The egg yolk and white were separated and
pooled per group, diluted 1:5 (wt/vol) in distilled water
and mixed thoroughly. After overnight incubation at
4 °C, the supernatant, containing the water-soluble
fraction of the egg yolk and white, respectively, was
collected for immunoglobulin quantification using
enzyme-linked immunosorbent assay (ELISA). Wells of a
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50 μL of a suspension of C. jejuni KC40 cells (2 × 107 cfu/
mL) in coating buffer (2.16 g Na2CO3.10H2O + 1.935 g
NaHCO3 in 500 mL H2O). Bacterial cells were either
heat-killed or processed to antigenic fractions by sonic-
ation as described above. Plates were incubated overnight
at 4 °C, after which the wells were washed three times
with HBSS followed by a final wash step using wash buffer
(WB; PBS + 0.1% Tween 20). Next, the wells were incu-
bated with 100 μL blocking buffer (BB; WB + 1% bovine
serum albumin) at room temperature (RT) for 1 h to re-
duce non-specific binding of antibodies. Subsequently,
100 μL of two-fold dilutions (in BB) of the supernatant
were added to the wells in triplicate. The plates were incu-
bated at RT for 90 min. After incubation, the wells were
washed three times using HBSS and once using WB and
100 μL of 1/10000 (in WB) of horseradish peroxidase
(HRP)-labelled anti-chicken IgY (Sigma), 1/20000 HRP-
labelled goat anti-chicken IgA (Bio-Connect, The
Netherlands) or 1/10000 HRP-labelled goat anti-
chicken IgM (Gallus Immunotech Inc., Canada) were
added to each well. After incubation and washing as de-
scribed above, 50 μL of 3,3′,5,5′-tetramethylbenzidine
(TMB; Sigma) substrate was added. After 10 min the
reaction was blocked by adding 50 μL 0.5M H2SO4 to
the wells. The absorbance was then measured at 450 nm
using an automated spectrophotometer. Antibody titres
from egg yolks/whites of immunized hens were reported
as the highest dilution where the optical density (OD) was
greater than the OD + three standard deviations of wells
containing yolk/white originating from birds that only
received adjuvant.Purification of IgY fraction from egg yolks
IgY was purified from the egg yolks according to the
method of Bird and Thorpe [14].Collection of broiler chicken intestinal mucus
Commercial and Campylobacter-free 14-d-old broiler
chicks were euthanized and the small intestine was col-
lected and gently rinsed with phosphate-buffered saline
(PBS) to remove fecal material. The mucus was scraped
from the mucosa with a glass slide covered in paraf-
ilm, diluted 1:3 with N-2-hydroxyethylpiperazine-N’-
2-ethanesulfonic acid (HEPES, 25 mM, pH 7.4) and
vortexed. The solution was centrifuged three times at
2000 × g for 15 min at 4 °C. The pooled supernatant
containing the crude mucus was centrifuged two times
more at 5000 × g for 15 min at 4 °C and stored at −80 °C.
Protein content was determined using a Coomassie
(Bradford) Protein Assay Kit according to the manufac-
turer’s instructions (Biorad, Nazareth, Belgium).Mucus adhesion test
The effect of IgY on the adherence of C. jejuni to intes-
tinal mucus was examined for the homolog C. jejuni
strain KC40 as well as for five other C. jejuni strains
(10kf-1.16, 7P6.12, 10C-6.1, 10kf-4.12 and 10VTDD-8).
Bacteria were first incubated for 30 min at 42 °C in
HBSS only or HBSS supplemented with purified IgY
from C. jejuni-immunized or HBSS/sham-immunized
hens. Mucus was diluted to a final concentration of
250 μg protein/mL in coating buffer. One hundred μL
were immobilized per well of a microtiter plate (Maxisorp,
Nunc) and incubated overnight at 4 °C. The wells were
washed three times with HBSS and saturated with 1% (wt/
vol) bovine serum albumin (BSA) in HBSS for 1 h at RT.
After washing the wells two times with HBSS, 100 μL of
the C. jejuni-IgY mixture were transferred to the wells.
After a 1 h incubation at 42 °C, the wells were washed 15
times to remove unbound bacteria. Wells were thereafter
treated with 200 μL 0.5% (vol/vol) Triton X-100 to release
adherent bacteria and incubated for 30 min at RT while
shaking. Next, 300 μL HBSS were added to each well
and 10-fold dilutions of the wells were titrated on
mCCDA plates.
Motility assay
To assess the influence of C. jejuni-specific IgY on C.
jejuni motility of the six strains used in the study, bac-
teria were pre-incubated with purified IgY from yolks of
either C. jejuni- or sham/HBSS-immunized laying hens
and 20 μL were pipetted onto semi-solid Mueller-Hinton
(MH) agar. After 24 h incubation at 42 °C under micro-
aerobic conditions, the diameter of Campylobacter growth
from both conditions was measured.
Multilocus sequence typing
To determine the relatedness between the C. jejuni
strains used in this study, all strains were characterized
by multilocus sequence typing (MLST) according to
[15]. For determination of the sequence type (ST) and
clonal complex (CC) all allelic sequences were queried
against the online C. jejuni MLST database [16].
Effect of in-feed hyperimmune egg yolk on transmission
of and cecal colonization with C. jejuni in two-week-old
broilers
In trial 1, day-of-hatch Campylobacter free broiler chicks
(n = 22) were raised in group. At 6 days of age the chicks
were randomly assigned to 2 groups (n = 11/group) and
housed in separate isolating chambers. Animals of group
1 were provided with feed containing 5% (wt/wt) egg
yolk (mixed manually through the feed) from hens
sham-immunized with HBSS/adjuvant, while birds of
group 2 were fed 5% (wt/wt) egg yolk from hens immu-
nized with a whole-cell C. jejuni lysate/adjuvant mixture.
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the experiment. Equal amounts of feed and drinking
water were provided for each group during treatment
and care was taken that all animals had unlimited access
to the feed and water. At the age of 10 days, three chicks
of both groups were orally inoculated with approxi-
mately 8 × 103 cfu of C. jejuni strain KC40. At 13 days of
age all animals were euthanized (as described above) and
the ceca as well as their contents were collected for
C. jejuni enumeration (see below).
In trial 2, day-of-hatch broiler chicks (n = 54) were
raised in group. At 6 days of age the chicks were ran-
domly assigned to 6 groups (n = 9/group) and housed in
separate isolating chambers. Animals of groups 1, 2 and
3 were provided with feed containing 5% (wt/wt) egg
yolk from hens immunized with HBSS/adjuvant, while
birds of groups 4, 5 and 6 were fed 5% (wt/wt) egg yolk
from hens immunized with the hydrophobic protein
fraction of C. jejuni mixed with adjuvant. At the age of
10 days, three chicks of each group were orally inocu-
lated with approximately 3 × 104 cfu of C. jejuni strain
KC40. At 13 days of age all animals were euthanized
(as described above) and the ceca as well as their contents
were collected for C. jejuni enumeration (see below).
Cecal Campylobacter jejuni enumeration
Ceca and contents were cut into small fragments,
weighed, and diluted 1:9 (wt/vol) in NB2 with supple-
ments. After homogenization, a 10-fold dilution series
was made in HBSS. Of each dilution, 100 μL were spread
on mCCDA plates. After 22 h incubation at 42 °C
under microaerobic conditions, characteristic colonies
were counted. For enrichment, diluted cecal samples in
NB2 were incubated at 37 °C under microaerobic con-
ditions. After 24 h, samples were plated on mCCDA
and incubated at 42 °C in a microaerobic environment.
After 24 and 48 h plates were examined for the pres-
ence or absence of C. jejuni.
Two-dimensional gel-electrophoresis and Western
blot analysis
To identify the immunodominant antigens of C. jejuni
recognized by yolk IgY of immunized hens, the whole C.
jejuni lysate was separated by iso-electric focussing
(pH 3–10), followed by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) with a
4% stacking gel and 10% separating gel at 150 V for
30 min and 200 V for 60 min as previously described
[17]. The separated proteins were transferred electrophor-
etically (50 V) onto nitrocellulose membranes (Bio-Rad)
for 3 h. After washing with milliQ water, the membrane
blots were blocked in 5% (wt/vol) milk in PBS for 1 h at
RT. Subsequently, the blots were incubated overnight with
purified egg yolk IgY, diluted to 1:5000 (vol/vol) in 5%(wt/vol) milk. After washing with 0.05% (vol/vol) Tween-20,
the blots were incubated with horseradish peroxidase-
conjugated goat-anti-chicken immunoglobulin G at a dilu-
tion of 1:50 000 in 5% (wt/vol) milk for 1 h. The blots
were washed and proteins were immunodetected by en-
hanced chemiluminescence, using Supersignal West Dura
Extended Duration Substrate (Pierce), and scanned and
digitized using the Versa Doc imaging system. Blotting
experiments were performed in duplicate to identify
antigens recognized by IgY in yolk from immunized/
sham-immunized laying hens.
In-gel digestion and mass spectrometric analysis
Spots of interest (C. jejuni antigens reacting with
hyperimmune egg yolk IgY) were cut out of the gel and
processed as previously described [18]. Prior to mass
spectrometry the isolated peptides were separated on a
U3000 nano-HPLC device (Dionex) as previously de-
scribed [19].
Identification of the peptides was performed on an
electrospray ionization quadrupole time of flight (ESI-
QUAD-TOF) spectrometer (Ultima, Waters). Peptides
were acquired in the range of 450 to 1650 m/z in MS.
The seven most abundant multiply charged ions with a
minimum intensity of 60 counts per second were sub-
jected to MS/MS (between 50 and 2300 m/z). m/z ratios
selected for MS/MS were excluded for 150 s.
Data analysis was performed against the Campylobacter
protein databank (124864 sequences) from NCBI using
the in-house search engine Mascot Daemon (2.3, Matrix
Science, London, UK). Carbamidomethyl (N-term), dea-
midation (NQ) and oxidation (M) were set as variable
modifications. Peptide mass tolerance and fragment mass
tolerance were set at 0.35 Da and 0.6 Da, respectively.
Maximum two miss cleavages were allowed. Proteins were
only considered to be positively matched if the significance
was below 0.01 (p ≤ 0.01) and at least one peptide passing
the required bold red criteria from Mascot Daemon,
indicating that at least one peptide had rank 1 and a
significance below 0.01.
Statistical analysis
Data were analyzed by SPSS 17.0 software for Windows.
The significance level α was set at 0.05. Campylobacter
counts were first transformed to log10 counts before
statistical analysis. For the in vivo trials, a non-
parametric Mann–Whitney U test was carried out to
compare the means of log10 transformed counts in
chicken cecal contents (of seeders, contact animals or
both) of all groups (treated and control groups). For the
mucus adhesion test, a one-way analysis of variance
(ANOVA) was carried out to compare the means of log10
transformed adherent bacteria of all groups (treated
groups and control groups). Significant differences were
Figure 1 Campylobacter jejuni binding to chicken intestinal mucus. Total adherent Campylobacter jejuni bacteria to chicken intestinal mucus
are shown after pre-incubation with HBSS (control, black rectangle symbol) or IgY derived from HBSS/sham-immunized (white rectangle symbol)
or C. jejuni-immunized hens (grey rectangle symbol). Values are represented as log10 cfu adherent bacteria/well. Statistical differences are denoted
with an asterisk (p < 0.05).
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0.05 were considered significantly different.
Results
Determination of antibody titers from egg
C. jejuni-specific IgY were detectable in egg yolk of hens
immunized with a C. jejuni lysate, resulting in titers of
up to 1:16000 as determined by ELISA (results not
shown). In contrast, C. jejuni-specific IgY in egg white
and C. jejuni-specific IgA and IgM in egg white and yolk
were not detectable after immunization.
In vitro anti-Campylobacter properties of egg yolk IgY
Pre-treatment with purified IgY from yolks of C. jejuni
KC40-immunized hens significantly (p < 0.05) promoted
bacterial binding of the homologous C. jejuni strain to
chicken intestinal mucus by approximately log10 2 com-
pared to IgY from HBSS/sham-immunized (control) ani-
mals (Figure 1). Increased bacterial binding to mucus
after pre-treatment with KC40-derived IgY compared
to control IgY was also observed for C. jejuni strainTable 1 Multilocus sequence type and clonal complex attribu
Isolate Sequence type Clonal complex aspA
KC40 794 677 10
10kf-1.16 267 283 4
7P6.12 464 464 24
10C-6.1 305 574 9
10kf-4.12 51 443 7
10VTDD-8 905 NA1 2
1not assigned.10kf-1.16 (p < 0.05), whereas the binding capacity of
the other four C. jejuni strains (7P6.12, 10C-6.1, 10kf-
4.12 and 10VTDD-8) remained unaltered (p > 0.05). All
six C. jejuni strains tested belong to a different clonal
complex, as proved by MLST analysis (Table 1), indi-
cating that C. jejuni strain KC40 and C. jejuni strain
10kf-1.16 are “true” heterologs. C. jejuni KC40-specific
IgY did not affect C. jejuni motility of any of the tested
strains (data not shown).
In vivo anti-Campylobacter properties of egg yolk IgY
In in vivo trial 1, the overall cecal C. jejuni numbers
(Figure 2) of inoculated (seeder) broilers receiving
hyper-immune egg yolks from C. jejuni whole-cell
lysate-immunized layers were reduced by > 5 log10 cfu
(p < 0.01) compared to control seeders, receiving yolks
from HBSS/sham-immunized hens (3.3 ± 1.2 vs. 8.4 ± 0.6
log10 cfu/g cecal contents). Moreover, transmission to
non-seeder (contact) chicks was completely prevented,
in contrast to the control group where seeder and non-
seeder birds (8.4 ± 0.6 vs. 7.3 ± 1.1 log10 cfu/g cecaltion of C. jejuni strains used in the study.
MLST allelic profile
glnA gltA glyA pgm tkt uncA
81 50 87 120 76 52
7 40 4 42 51 1
2 2 2 10 3 1
53 2 10 11 3 3
17 2 15 23 3 12
15 4 3 154 25 35
Figure 2 Reduced cecal Campylobacter jejuni colonization with
yolks from hens immunized with a whole-cell lysate of C. jejuni.
Individual and mean (▬) cecal C. jejuni counts of two-week-old
co-housed broiler seeders (●) and sentinels (○) receiving standard
feed supplemented with 5% (wt/wt) egg yolk from either HBSS/
sham-immunized (left) or C. jejuni immunized (right) layers, from day
six until the end of the experiment, are shown. Values are represented
as log10 cfu/g cecal content. At 10 days of age, seeder animals were
inoculated with approximately 8 × 103 cfu of C. jejuni KC40.
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Together, this lead to a dramatic reduction (p < 0.001) in
the overall cecal C. jejuni count by log10 6.7 for birds
receiving hyperimmune yolk (0.9 ± 1.6 log10 cfu/g cecal
contents) compared to birds receiving control yolks
(7.6 ± 1.1 log10 cfu/g cecal contents).
In in vivo trial 2, the protective effect of IgY induced
against the outer-membrane proteins of C. jejuni was
investigated. In two of the three replicate experiments
(Figure 3A and B) a significant (p ≤ 0.05) reduction in
cecal C. jejuni counts was observed in seeder animals
(by respectively 3.3 and 1.6 log10 cfu/g cecal contents)
fed hyperimmune egg yolk compared to control birds. Inthe third replicate (Figure 3C), counts were reduced
(p > 0.05) by 1.1 log10 cfu. In replicate 1, transmission
to contact birds was completely prevented, while in repli-
cate 2 and 3 cecal counts were significantly reduced by re-
spectively 3.6 and 6.1 (p < 0.01) log10 cfu/g cecal contents)
when birds were fed hyperimmune egg yolk. Together, this
resulted in an overall reduced cecal C. jejuni count in the
replicate experiments of respectively 5.6 (p = 0.001), 2.9
(p = 0.001) and 4.5 (p < 0.05) log10 cfu/g. Averaged over
three replicates, cecal C. jejuni numbers of inoculated
broilers receiving hyper-immune egg yolks from layers
immunized with the hydrophobic protein fraction of
C. jejuni were reduced by two log10 cfu (p = 0.002)
compared to control animals (6.0 ± 1.8 vs. 8.0 ± 0.4
log10 cfu/g cecal contents), while transmission to con-
tact birds was greatly (p < 0.001) reduced (1.5 ± 2.5 vs.
7.0 ± 1.1 log10 cfu/g cecal contents). Together, this lead
to a dramatic reduction (p < 0.001) in the overall cecal
C. jejuni count by log10 4.4 for broilers receiving hyper-
immune yolk (3.0 ± 3.2 log10 cfu/g cecal contents) com-
pared to birds receiving control yolks (7.4 ± 1.0 log10
cfu/g cecal contents).
Identification of immunodominant C. jejuni KC40 antigens
Western blots from 2-dimensional separated C. jejuni
proteins immunostained with IgY from egg yolk of C.
jejuni whole-cell lysate-immunized laying hens revealed
several immunodominant antigens (Figure 4A), while
blots stained with IgY from HBSS/sham-immunized hens
showed only marginal reactivity (data not shown). Spots
that were preferentially present on the Western blot
immunostained with purified IgY from yolks of lay-
ing hens immunized with C. jejuni were linked to
the 2-dimensionally separated C. jejuni proteins on
the gel (Figure 4B), digested in peptides with trypsin
and subjected to mass spectrometric (MS) analysis.
Proteins with a Mascot score of < 56 (p < 0.01) or present
in only one of duplicate experiments were excluded from
the study. MS analysis identified several of the immu-
nodominant antigens of C. jejuni KC40, represented in
Table 2.
Discussion
Immunizing laying hens and subsequently collecting
their eggs is a cheap and straightforward method to ob-
tain high amounts of specific antibodies [6,11]. In our
study, C. jejuni-specific IgY was dramatically induced in
egg yolk of hens immunized with a C. jejuni whole-cell
lysate, resulting in titers of up to 1:16 000 as determined
by ELISA. In contrast, specific IgY in egg white and spe-
cific IgA and IgM in egg white and yolk were not signifi-
cantly induced after immunization. This indicates that
only transfer of IgY to egg yolk is biologically relevant in
the overall transfer of immunoglobulins into eggs after
A B C
Figure 3 Reduced cecal Campylobacter jejuni colonization with yolks from hens immunized with C. jejuni hydrophobic proteins.
Individual and mean (▬) cecal C. jejuni counts of two-week-old co-housed broiler seeders (●) and sentinels (○) receiving standard feed supplemented
with 5% (wt/wt) egg yolk from either HBSS/sham-immunized (left) or C. jejuni immunized (right) layers, from day six until the end of the experiment,
are shown. Values are represented as log10 cfu/g cecal content. At 10 days of age, seeder animals were inoculated with approximately 3 × 10
4 cfu of C.
jejuni KC40. The experiment was performed in triplicate and results of all replicates are shown (A-C).
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et al. [20].
In the first in vivo trial, using the whole-cell lysate of
C. jejuni, broiler chicks were provided with feed supple-
mented with (hyperimmune) egg yolks from day seven
onward. At 10 days of age three out of 11 birds were
orally inoculated with approximately 8 × 103 cfu of C.
jejuni. Colonization of these seeder animals is supposed
to result in transmission of C. jejuni to the remainder of
the birds. Three days after inoculation, cecal C. jejuni
numbers of seeder birds receiving hyperimmune egg
yolk were significantly reduced compared to control
seeders without IgY (by over 5 logs). Moreover, none of
the contact birds were colonized with C. jejuni, while
chicks receiving control eggs carried high (ca. log10
7 cfu/g) bacterial numbers in their ceca. It is not clear at
what site (the cecum or more proximal in the GI tract)
the IgY fraction was active, but clearly it captured
ingested C. jejuni bacteria, disabling them to colonize
and transmit to other birds. In addition, specific IgY in-
creased bacterial binding of C. jejuni to chicken intes-
tinal mucus, suggesting that it promotes bacterial uptake
in the mucus layer for enhanced mucosal clearance.
Because several of the identified immunodominant anti-
gens are believed to be associated with the bacterial
outer-membrane, a second (analogous) in vivo trial was
performed using egg yolks containing IgY against only
the hydrophobic protein fraction of C. jejuni. Althoughthe effects observed in this second in vivo trial were less
pronounced compared to the results obtained in the first
in vivo trial using IgY against the whole-cell lysate of
C. jejuni (probably due to the higher inoculation dose of
the seeders (3 × 104 cfu vs. 8 × 103 cfu)), hyperimmune
yolks reduced cecal bacterial counts of seeders by 2
log10 cfu and dramatically reduced C. jejuni transmission
to contact birds, indicating that the hydrophobic protein
fraction is important for immunization but that also
non-hydrophobic proteins may be involved in this im-
mune response. Previous passive immunization studies
with Salmonella enterica by other researchers [21] indi-
cated no significant effect on cecal colonization of
broilers receiving feed supplemented with freeze-dried
egg yolk powder containing anti-Salmonella enterica
IgY. Cecal Salmonella counts in birds receiving feed
supplemented with 5% (wt/wt) yolk powder on day 3
post-inoculation were, however, (non-significantly) re-
duced by three logs compared to control birds. These
authors suggested that the antibodies were denatured
and degraded along the GI tract, thereby reaching the
ceca at insufficient concentrations, but it cannot be
ruled out that a significant reduction could be achieved
using more animals per group. In our study, egg yolks
were administered as such to exclude degradation during
freeze-drying. This might indicate that egg yolks form a
protective matrix allowing IgY to survive the digestive
enzymes and the low pH along the GI tract [11]. Other
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Figure 4 Western blot reacted with yolk immunoglobulin Y of hens immunized with a whole-cell C. jejuni lysate (A) and Campylobacter
jejuni KC40 2D-proteome profile (B). A total protein extract of C. jejuni KC40 was separated by 2-dimensional gelelectrophoresis and separated
proteins were detected by SYPRO® RUBY Protein staining. Immunoreactive antigens are indicated with a number and were excised from the gel
and sequenced using mass spectrometry. Identified proteins are indicated by the spot numbers given in Table 2.
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come between our study and that of Chalghoumi et al.
[21] include (1) age of the animals at challenge, (2) experi-
mental set-up, since we used a seeder experiment while all
birds were challenged with Salmonella, (3) immunization
protocol and (4) bacterium-specific differences between
Salmonella enterica and C. jejuni.
We identified the most likely C. jejuni proteins respon-
sible for the induction of specific IgY. Because a C. jejuni
whole-cell lysate was used, specific IgY could be induced
against both membrane-bound as well as cytoplasmic pro-
teins. Although our obtained results are fairly consistent
with those reported in other studies examining antigenic
proteins of C. jejuni, there was a striking absence in
our study of Omp18, Cme, Cja and PEB proteins, iden-
tified in another study [22]. These differences might be
in part explained by C. jejuni strain differences. In
addition, it is not clear whether repeated immunization ofchickens in their breast muscle could lead to a different
immune response compared to that observed during
natural gut colonization with C. jejuni.
A first group of proteins that reacted with the purified
egg yolk IgY are flagellar proteins: flagellar hook protein
FlgE, major flagellin FlaA and minor flagellin FlaB. FlgE
and FlaA are known to be immunogenic and are needed
for full motility of C. jejuni [22,23]. In addition, FlgE
mediates flagellar assembly and protein secretion in
C. jejuni [22], while FlaA mutation may result in reduced
colonization in chicks [24]. These results are consistent
with Shoaf-Sweeney et al. [22] who reported the pres-
ence of maternal antibodies reacting with these flagellar
proteins in the serum of laying hens. Despite these fla-
gellar proteins, which were shown to be highly immuno-
genic in this study, specific IgY did not affect C. jejuni
motility. The major outer-membrane protein (MOMP)
of C. jejuni, encoded by the porA gene, was identified in
Table 2 Predicted immunodominant Campylobacter jejuni KC40 antigens identified with HPLC-MS/MS.
Spot no. Protein name Gene Mascot score MW (kDa) pI
1 Flagellar hook protein flgE 1928 90.1 4.85
2 Flagellin subunit protein A flaA 4958 59.2 5.7
Co-chaperonin GroEL groEL 3281 58 5.02
Flagellin subunit protein B flaB 1476 59.4 5.66
Flagellin subunit protein B flaB 1048 26.3 5.52
3 Flagellin subunit protein A flaA 693 58.8 5.53
Co-chaperonin GroEL groEL 493 58 5.02
4 Major outer membrane protein omp 3071 43.1 4.54
Glutamate-1-semialdehyde-2,1-aminomutase hemL 356 46.5 8.92
Glutathionylspermidine synthase family protein 164 44.8 4.59
5 Major outer membrane protein omp 1011 43.1 4.54
6 Translation elongation factor thermo unstable eF-Tu 2172 43.6 5.11
ATP-dependent Clp protease, ATP-binding subunit clpX 311 46.1 5.21
Major outer membrane protein omp 66 36 4.53
7 Chemotaxis protein V cheV 1552 35.8 4.92
Translation elongation factor thermo unstable eF-Tu 461 45 5.43
Glycyl-tRNA synthetase alpha subunit glyQ 148 24.3 4.6
Phosphoribosylformylglycinamidine cyclo-ligase purM 70 36 5.07
8 FKBP-type peptidyl-prolyl cis-trans isomerase slyD 743 20.5 4.75
Chemotaxis protein V cheV 330 35.8 4.92
Inorganic pyrophosphatase ppa 308 19.4 4.79
Translation elongation factor thermo unstable eF-Tu 226 43.6 5.11
Heat shock protein GrpE grpE 168 20.2 4.79
9 Translation elongation factor thermo unstable eF-Tu 96 43.6 5.11
10 Branched-chain amino acid aminotransferase ilvE 551 33.1 6.12
Enoyl-(acyl-carrier-protein) reductase fabI 354 30 5.67
Putative methyltransferase 174 29.8 5.92
11 Methyl-accepting chemotaxis protein 811 40.6 5.5
Succinyl-CoA synthetase beta chain 502 41.9 5.61
Cysteine desulfurase, putative 472 43.2 5.83
Phosphoglycerate kinase pgk 216 43.9 6.07
12 Conserved hypothetical protein 568 53 6.28
Pyruvate kinase pyk 420 54 5.68
Glutamyl-tRNA synthetase gltX-1 306 53.3 6.19
ATP synthase F1, alpha subunit atpA 343 53.4 5.73
Trigger factor tig 255 50.9 5.69
Aspartate ammonia-lyase aspA 219 52.1 5.5
Fumarate hydratase fumC 131 23.2 6.05
13 ATP synthase F1, alpha subunit atpA 856 53.4 5.73
GMP synthase (glutamine-hydrolyzing) guaA 580 57.4 6.19
14 ATP synthase F1, alpha subunit atpA 1014 53.4 5.73
Peptide transport system substrate-binding protein 488 58.7 6.52
Acetyl-CoA carboxylase, biotin carboxylase accC-2 128 54.9 6.4
15 Putative secreted carboxyl-terminal protease ctpA 1607 48.3 8.7
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Table 2 Predicted immunodominant Campylobacter jejuni KC40 antigens identified with HPLC-MS/MS. (Continued)
16 Putative secreted carboxyl-terminal protease ctpA 717 48.3 8.7
17 High affinity branched-chain amino acid ABC transporter,
periplasmic amino acid-binding protein
420 39.9 8.94
Hydrogenase expression/formation protein hypD 151 40.9 8.59
18 Dihydrodipicolinate synthase dapA 315 33 6.02
Putative UDP-glucose 4-epimerase 214 35.6 7
O-acetylserine sulfhydrylase B cysM 201 32.5 6.62
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jejuni proteome [25]. In addition to being immunogenic
[26], MOMP is involved in adhesion and transmembrane
ion transport in C. jejuni [25]. However, MOMP is ex-
tremely genetically diverse and several conformational
epitopes have been implicated in the induction of pro-
tective immunity [26], thereby possibly hindering its use
in vaccine applications. Methyl-accepting chemotaxis
(MCP) proteins are transmembrane receptors for chemo-
tactic stimuli [23]. Attached to these transmembrane re-
ceptors is the C. jejuni chemotaxis protein V (CheV), a
coupling protein involved in transducing chemotactic
signals in C. jejuni [27], which was also identified in
this study. Another immunodominant protein was the
branched-chain amino acid ATP-binding cassette trans-
port protein LivJ, a periplasmic binding protein prob-
ably involved in transporting amino acids into the
bacterial cell [28] and crucial for chick colonization
[22]. An additional role for LivJ in the interaction of
C. jejuni with the chick cecum was suggested by
Ribardo and Hendrixson [28]. ATP synthase is abun-
dantly present and highly conserved among bacteria
[29]. The protein is associated with the membrane
where it performs its role in energy metabolism. In this
study, the alpha subunit of ATP synthase F1 (AtpA)
was found to be immunogenic in C. jejuni, as already
reported for C. concisus [29].
Several of the identified antigens in this study were
proteins mainly located in the bacterial cytoplasm where
they perform their respective functions. Some of these
antigens may nevertheless be interesting candidates for
vaccine development. GroEL is an extremely conserved
[30] 60-kDa heat shock protein that plays a crucial role
in the C. jejuni stress response and has previously been
shown to be an immunodominant antigen of C. jejuni
[31]. Although mainly located in the bacterial cytoplasm,
in Salmonella Typhymurium (and other bacteria) GroEL
is suggested to be expressed on the cell surface as well
since it has been shown to mediate Salmonella adhesion
[32]. The highly conserved translation elongation factor
thermo unstable (EF-Tu) was found to be abundantly
present in the C. jejuni whole-cell lysate, which is in line
with observations in other bacteria [33]. Despite itscytoplasmic role during protein synthesis, EF-Tu was
shown to be translocated to the surface in several bacteria,
where it mediates adhesion and invasion of host cells [33].
Immunization of mice with Burkholderia pseudomallei
EF-Tu resulted in a potent immune response that was
partially protective against melioidosis. Finally, a putative
secreted carboxyl-terminal protease of C. jejuni, CtpA,
was identified. This protein has been shown to be highly
prevalent and conserved in Burkholderia mallei, another
Gram-negative bacterium [34]. The exact function, as well
as prevalence and conservation of CtpA in C. jejuni is less
understood, but the immunodominance of this protein
indicates CtpA might be an interesting candidate for sub-
unit vaccin development.
This study reports some promising observations, but
further research is needed before a commercial product
can be promoted. First of all, it needs to be established
whether this protective effect is maintained over periods
exceeding three days post-inoculation. Second, the
immunization protocol and the yolk dose in the feed need
to be optimized. Further research will also have to eluci-
date whether this strategy is capable of providing cross-
protection against heterologous C. jejuni strains. The in-
creased mucosal adherence observed for at least one of
the heterologous C. jejuni strains tested in this study, sug-
gests that (partial) cross-protection may be attained, but
in vivo trials are necessary to proof this hypothesis. Even-
tually, this may lead to the development of a passive
immunization strategy that can successfully control C.
jejuni in chickens. If the relevant protective antigens of C.
jejuni could be identified and studies regarding conser-
vation and prevalence among C. jejuni strains are
conducted, subunit vaccines able to target a wide
range of C. jejuni strains could be developed and
used for immunization of hens in order to prepare
yolks for passive immunization applications.
To conclude, we here demonstrate for the first time that
feeding broilers IgY-rich yolks from hens immunized with
C. jejuni dramatically reduces both C. jejuni numbers in the
ceca after challenge with the homologous strain and trans-
mission to non-inoculated contact birds, providing a solid
base for further research regarding passive immunization
to control C. jejuni colonization in broiler flocks.
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